RASTETTER WILLIAM H
Insider CIK 1205903 · ILMN Director · CERU Director · FATE Director · RCPT Director · RGLS Director · IAM Director · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 8,341 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 14,972 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 36,805 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 64,001 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 76,801 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 8,341 | — | — | 200,920 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 192,579 | — | — | 192,579 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 40,600 | — | $0 | 40,600 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award | 2026-06-30 | 2026-07-02 | 38,862 | — | $0 | 39,721 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2026-06-12 | 2026-06-15 | 87,900 | — | $0 | 87,900 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2026-06-11 | 2026-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 2,567 | — | $0 | 2,567 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 43,678 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2026-05-05 | 2026-05-06 | 25,000 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2026-05-05 | 2026-05-06 | 25,000 | $1.69 | $42.3K | 36,331 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-11-05 | 2025-11-06 | 18,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-11-05 | 2025-11-06 | 18,000 | $151.82 | $2.73M | 40,360 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-11-05 | 2025-11-06 | 18,000 | $47.89 | $862.0K | 58,360 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2025-07-09 | 2025-07-10 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 60,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 9,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 4,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 4,650 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 2,325 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 57,292 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | U Tender | 2025-06-25 | 2025-06-27 | 44,264 | — | $0 | 57,292 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-05-29 | 2025-05-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 40,360 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,318 | — | $0 | 3,318 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-05 | 2025-05-07 | 30,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-05-05 | 2025-05-07 | 30,000 | $110.20 | $3.31M | 37,491 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-05 | 2025-05-07 | 30,000 | $42.76 | $1.28M | 67,491 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-04-30 | 2025-04-30 | 62,500 | — | $0 | 101,556 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-15 | 2024-08-16 | 14,250 | $146.69 | $2.09M | 37,491 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 2,869 | — | $0 | 2,869 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-16 | 2024-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-01-02 | 2024-01-04 | 20,000 | $12.98 | $259.6K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-02 | 2024-01-04 | 11,044 | $131.47 | $1.45M | 51,741 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-01-02 | 2024-01-04 | 20,000 | $12.98 | $259.6K | 62,785 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2023-06-21 | 2023-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-06-13 | 2023-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 8,579 | — | $0 | 8,579 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-05-01 | 2023-05-03 | 7,625 | $12.71 | $96.9K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-05-01 | 2023-05-03 | 7,625 | $12.71 | $96.9K | 47,085 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-05-01 | 2023-05-03 | 4,300 | $101.43 | $436.1K | 42,785 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-04-21 | 2023-04-21 | 10,765 | $12.71 | $136.8K | 7,625 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-04-21 | 2023-04-21 | 6,034 | $105.04 | $633.8K | 39,460 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-04-21 | 2023-04-21 | 10,765 | $12.71 | $136.8K | 45,494 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-04-19 | 2023-04-21 | 1,610 | $12.71 | $20.5K | 18,390 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-04-19 | 2023-04-21 | 903 | $105.00 | $94.8K | 34,729 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-04-19 | 2023-04-21 | 1,610 | $12.71 | $20.5K | 35,632 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 38,000 | — | $0 | 38,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 11,331 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-05-18 | 2022-05-20 | 9,724 | — | $0 | 9,724 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-04-01 | 2022-04-05 | 20,000 | $6.66 | $133.2K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-04-01 | 2022-04-05 | 20,000 | $6.66 | $133.2K | 44,750 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-04-01 | 2022-04-05 | 10,728 | $94.93 | $1.02M | 34,022 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2021-06-24 | 2021-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-06-14 | 2021-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 4,334 | — | $0 | 4,334 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-06-02 | 2021-06-04 | 2,681 | — | $0 | 2,681 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-05-19 | 2021-05-20 | 8,833 | — | $0 | 8,833 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2020-06-25 | 2020-06-26 | 22,500 | — | $0 | 22,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 23,250 | — | $0 | 23,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-05-19 | 2020-05-21 | 6,018 | — | $0 | 6,018 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | G Gift | 2020-03-30 | 2021-04-02 | 28,461 | — | $0 | 146,821 | SEC↗ |
| FATE FATE THERAPEUTICS INC | G Gift | 2020-03-30 | 2021-04-02 | 28,461 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2020-03-30 | 2020-03-31 | 28,461 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2020-03-30 | 2020-03-31 | 28,461 | $1.37 | $39.0K | 28,461 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion deriv | 2020-02-03 | 2020-02-04 | 22,594 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion | 2020-02-03 | 2020-02-04 | 225,940 | — | $0 | 390,584 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-12-24 | 2019-12-26 | 22,594 | $6.66 | $150.5K | 22,594 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-12-24 | 2019-12-26 | 225,940 | $0.13 | $29.4K | 225,940 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 46,500 | — | $0 | 46,500 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2019-06-13 | 2019-06-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-05-22 | 2019-05-23 | 13,000 | — | $0 | 13,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-08 | 92,889 | $0.13 | $12.1K | 92,889 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-07 | 2019-05-21 | 92,889 | $0.13 | $12.1K | 92,889 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-08 | 92,889 | $1.08 | $100.3K | 154,223 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-05-07 | 2019-05-21 | 92,889 | $1.08 | $100.3K | 154,223 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2019-05-03 | 2019-05-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 1,458 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 6,250 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 3,051 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 4,583 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 1,458 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 1,458 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2018-11-12 | 2018-11-13 | 23,258 | — | $0 | 79,672 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2018-07-10 | 2018-07-11 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-05-24 | 2018-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-05-17 | 2018-05-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2018-05-02 | 2018-05-04 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-01-24 | 2018-01-26 | 20,000 | $7.05 | $141.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-01-24 | 2018-01-26 | 9,500 | $90.00 | $855.0K | 24,750 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-01-24 | 2018-01-26 | 20,000 | $7.05 | $141.0K | 34,250 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2017-12-04 | 2017-12-06 | 69,662 | $0.89 | $62.0K | 694,387 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2017-07-25 | 2017-07-25 | 274,725 | $0.91 | $250.0K | 624,625 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2017-07-19 | 2017-12-08 | 2,000 | — | $0 | 2,000 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 2,000 | — | $0 | 2,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-05-22 | 2017-06-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2017-05-02 | 2017-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2017-03-07 | 2017-03-07 | 250,000 | $1.15 | $287.5K | 350,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-02-01 | 2017-02-02 | 25,000 | $2.17 | $54.3K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-01 | 2017-02-02 | 10,750 | $42.28 | $454.5K | 14,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-02-01 | 2017-02-02 | 25,000 | $2.17 | $54.3K | 25,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award | 2017-01-03 | 2017-01-05 | 24,350 | $0.77 | $18.7K | 103,039 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2016-11-23 | 2016-11-28 | 375,939 | $2.66 | $1000.0K | 459,272 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award | 2016-10-03 | 2016-10-20 | 18,382 | $1.02 | $18.7K | 78,689 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2016-06-02 | 2016-06-03 | 36,620 | — | $0 | 36,620 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-05-20 | 2016-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2016-05-11 | 2016-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2015-12-31 | 2016-01-04 | 182 | $164.14 | $29.9K | 8,494 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2015-09-30 | 2015-10-02 | 145 | $205.90 | $29.9K | 8,312 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 9,400 | $204.56 | $1.92M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 18,800 | $213.23 | $4.01M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,400 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 332,234 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2015-07-21 | 2015-07-21 | 61,235 | $10.19 | $624.0K | 100,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2015-07-20 | 2015-07-21 | 38,765 | $10.13 | $392.7K | 38,765 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2015-06-30 | 2015-07-01 | 149 | $201.07 | $30.0K | 8,167 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 8,214 | — | $0 | 8,214 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2015-06-10 | 2015-06-26 | 17,500 | — | $0 | 17,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-05-28 | 2016-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-05-28 | 2015-06-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-05-28 | 2015-06-01 | 7,400 | — | $0 | 7,400 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2015-05-27 | 2015-05-28 | 1,910 | — | $0 | 8,018 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-05-13 | 2015-05-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2015-03-31 | 2015-04-02 | 155 | $193.28 | $30.0K | 6,108 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2015-01-20 | 2015-01-22 | 16,000 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 800 | $189.12 | $151.3K | 12,730 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2015-01-20 | 2015-01-22 | 16,000 | $6.23 | $99.7K | 21,953 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 5,850 | $184.85 | $1.08M | 16,103 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 2,373 | $185.90 | $441.1K | 13,730 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 200 | $187.57 | $37.5K | 13,530 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 907 | $193.88 | $175.8K | 9,836 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 844 | $190.23 | $160.6K | 11,886 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 600 | $191.09 | $114.7K | 11,286 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 543 | $192.60 | $104.6K | 10,743 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 200 | $195.52 | $39.1K | 5,953 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2015-01-20 | 2015-01-22 | 3,683 | $194.91 | $717.9K | 6,153 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2014-12-31 | 2015-01-02 | 160 | $179.56 | $28.7K | 5,953 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2014-09-30 | 2014-09-30 | 167 | $172.12 | $28.7K | 5,793 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-09-29 | 2014-09-30 | 248 | $163.73 | $40.6K | 5,626 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2014-06-30 | 2014-07-01 | 187 | — | $0 | 5,874 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-06-30 | 2014-07-01 | 334 | $174.34 | $58.2K | 5,687 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-06-06 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 9,400 | — | $0 | 9,400 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2014-05-28 | 2014-05-29 | 2,542 | — | $0 | 6,021 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-05-22 | 2014-05-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | A Award deriv | 2014-05-22 | 2014-05-22 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-04-21 | 2014-04-22 | 879 | $135.82 | $119.4K | 3,479 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 380 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 5,522 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 110,107 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 118,954 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 31,500 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 22,801 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-17 | 76,923 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | J Other deriv | 2014-04-15 | 2014-04-17 | 0 | — | $0 | 380 | SEC↗ |
| CERU Cerulean Pharma Inc. | J Other deriv | 2014-04-15 | 2014-04-17 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 5,146 | — | $0 | 41,438 | SEC↗ |
| CERU Cerulean Pharma Inc. | P Buy | 2014-04-15 | 2014-04-17 | 18,869 | $7.00 | $132.1K | 60,307 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 8,199 | — | $0 | 23,749 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 2,576 | — | $0 | 9,682 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 7,106 | — | $0 | 7,106 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 5,868 | — | $0 | 15,550 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 7,589 | — | $0 | 31,338 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-17 | 4,954 | — | $0 | 36,292 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-03-31 | 2014-04-01 | 296 | $143.50 | $42.5K | 4,168 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2014-03-31 | 2014-04-01 | 190 | — | $0 | 4,358 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-02-03 | 2014-02-05 | 2,901 | $151.98 | $440.9K | 7,733 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-02-03 | 2014-02-05 | 3,169 | $152.90 | $484.5K | 4,564 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-02-03 | 2014-02-05 | 100 | $153.75 | $15.4K | 4,464 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2014-02-03 | 2014-02-05 | 2,381 | $150.51 | $358.4K | 10,634 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-01-03 | 2014-01-03 | 37,359 | $30.85 | $1.15M | 1,267,821 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-01-02 | 2014-01-03 | 27,581 | $30.29 | $835.4K | 1,305,180 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-12-31 | 2014-01-02 | 207 | — | $0 | 13,015 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-12-05 | 2013-12-06 | 500,000 | $27.63 | $13.81M | 1,332,761 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-11-21 | 2013-11-25 | 250,000 | $22.05 | $5.51M | 1,832,761 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-10-28 | 2013-10-30 | 20,000 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-10-28 | 2013-10-30 | 20,000 | $3.24 | $64.8K | 32,808 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-10-28 | 2013-10-30 | 18,051 | $92.32 | $1.67M | 14,757 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-10-28 | 2013-10-30 | 1,949 | $92.86 | $181.0K | 12,808 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2013-10-04 | 2013-10-07 | 83,333 | $6.00 | $500.0K | 83,333 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-09-27 | 2013-10-01 | 248 | — | $0 | 12,808 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 18,800 | — | $0 | 18,800 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-06-28 | 2013-07-02 | 334 | — | $0 | 12,560 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2013-06-10 | 2013-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ILMN ILLUMINA INC | A Award deriv | 2013-05-29 | 2013-05-31 | 7,600 | — | $0 | 7,600 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-05-29 | 2013-05-31 | 2,500 | — | $0 | 12,226 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2013-05-23 | 2013-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 502,720 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 851,291 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 4,131,552 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 8,640,289 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 265,567 | $14.00 | $3.72M | 2,082,761 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 67,029 | $7.73 | $518.1K | 260,806 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 113,505 | $5.25 | $595.9K | 193,777 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 550,872 | $7.73 | $4.26M | 1,817,194 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 1,152,038 | $5.25 | $6.05M | 1,266,322 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 71,428 | $14.00 | $1000.0K | 71,428 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-04-18 | 2013-04-22 | 576 | $56.33 | $32.4K | 9,711 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-04-18 | 2013-04-22 | 15 | — | $0 | 9,726 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 20,000 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-08 | 2013-04-10 | 20,000 | $1.04 | $20.8K | 30,287 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-08 | 2013-04-10 | 20,000 | $54.95 | $1.10M | 10,287 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2013-04-01 | 2013-04-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-03-28 | 2013-04-01 | 296 | — | $0 | 10,287 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-01-03 | 2013-01-07 | 300 | — | $0 | 9,991 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-10-01 | 2012-10-03 | 350 | — | $0 | 9,691 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-07-03 | 2012-07-05 | 340 | $44.95 | $15.3K | 9,341 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2012-05-23 | 2012-05-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ILMN ILLUMINA INC | A Award deriv | 2012-04-18 | 2012-04-20 | 10,800 | — | $0 | 10,800 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-04-18 | 2012-04-20 | 1,440 | — | $0 | 9,001 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-04-05 | 2012-04-09 | 321 | — | $0 | 7,561 | SEC↗ |